Two Sigma Advisers’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,700
| Closed | -$314K | – | 1259 |
|
|
2025
Q4 | $314K | Sell |
14,700
-2,700
| -16% | -$55.3K | ﹤0.01% | 1963 |
|
|
2025
Q3 | $291K | Sell |
17,400
-2,100
| -11% | -$31.5K | ﹤0.01% | 1999 |
|
|
2025
Q2 | $280K | Buy |
19,500
+2,800
| +17% | +$38.4K | ﹤0.01% | 1989 |
|
|
2025
Q1 | $242K | Sell |
16,700
-300
| -2% | -$4.26K | ﹤0.01% | 2065 |
|
|
2024
Q4 | $223K | Sell |
17,000
-40,600
| -70% | -$560K | ﹤0.01% | 2092 |
|
|
2024
Q3 | $668K | Sell |
57,600
-89,800
| -61% | -$847K | ﹤0.01% | 1591 |
|
|
2024
Q2 | $1.11M | Sell |
147,400
-6,400
| -4% | -$52.9K | ﹤0.01% | 1496 |
|
|
2024
Q1 | $1.54M | Sell |
153,800
-43,400
| -22% | -$404K | ﹤0.01% | 1361 |
|
|
2023
Q4 | $1.83M | Buy |
197,200
+13,500
| +7% | +$140K | ﹤0.01% | 1332 |
|
|
2023
Q3 | $2.33M | Buy |
183,700
+122,600
| +201% | +$1.68M | 0.01% | 1114 |
|
|
2023
Q2 | $868K | Buy |
61,100
+37,800
| +162% | +$531K | ﹤0.01% | 1593 |
|
|
2023
Q1 | $347K | Buy |
+23,300
| New | +$353K | ﹤0.01% | 2088 |
|
|
2022
Q2 | – | Sell |
-52,500
| Closed | -$1.23M | – | 2796 |
|
|
2022
Q1 | $1.23M | Sell |
52,500
-12,400
| -19% | -$304K | ﹤0.01% | 1524 |
|
|
2021
Q4 | $1.77M | Sell |
64,900
-68,400
| -51% | -$1.83M | ﹤0.01% | 1261 |
|
|
2021
Q3 | $3.79M | Sell |
133,300
-65,700
| -33% | -$2M | 0.01% | 920 |
|
|
2021
Q2 | $6M | Sell |
199,000
-169,000
| -46% | -$4.99M | 0.02% | 781 |
|
|
2021
Q1 | $9.37M | Sell |
368,000
-1,300
| -0.4% | -$33.3K | 0.03% | 595 |
|
|
2020
Q4 | $9.06M | Buy |
369,300
+54,300
| +17% | +$1.02M | 0.02% | 601 |
|
|
2020
Q3 | $5.13M | Buy |
315,000
+38,400
| +14% | +$714K | 0.01% | 757 |
|
|
2020
Q2 | $4.73M | Sell |
276,600
-700
| -0.3% | -$10.4K | 0.01% | 823 |
|
|
2020
Q1 | $3.23M | Buy |
277,300
+181,000
| +188% | +$3.73M | 0.01% | 877 |
|
|
2019
Q4 | $2.68M | Buy |
+96,300
| New | +$2.41M | 0.01% | 1090 |
|
|
2019
Q3 | – | Sell |
-70,700
| Closed | -$1.78M | – | 2327 |
|
|
2019
Q2 | $1.78M | Buy |
+70,700
| New | +$1.9M | ﹤0.01% | 1260 |
|
|
2018
Q1 | – | Sell |
-11,084
| Closed | -$592K | – | 2365 |
|
|
2017
Q4 | $592K | Sell |
11,084
-13,638
| -55% | -$643K | ﹤0.01% | 1726 |
|
|
2017
Q3 | $1.07M | Buy |
+24,722
| New | +$1.17M | ﹤0.01% | 1462 |
|
|
2015
Q1 | – | Sell |
-6,060
| Closed | -$401K | – | 2191 |
|
|
2014
Q4 | $401K | Buy |
+6,060
| New | +$370K | ﹤0.01% | 1758 |
|
|
2014
Q2 | – | Sell |
-23,960
| Closed | -$1.49M | – | 2590 |
|
|
2014
Q1 | $1.49M | Buy |
23,960
+19,300
| +414% | +$1.12M | 0.01% | 919 |
|
|
2013
Q4 | $248K | Buy |
+4,660
| New | +$250K | ﹤0.01% | 2010 |
|
|
2013
Q3 | – | Sell |
-13,460
| Closed | -$616K | – | 2278 |
|
|
2013
Q2 | $616K | Buy |
+13,460
| New | +$602K | 0.01% | 1192 |
|
Other funds holding MD
WA
Two Sigma Advisers's MD Position: Q1 2026 in Review
Two Sigma Advisers sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 14,700 shares — an estimated $314K sold.
Two Sigma Advisers first reported a position in MD in Q2 2013 and held it in 29 quarters. The position peaked at $9.37M in Q1 2021. 297 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Two Sigma Advisers reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 14,700 Pediatrix Medical shares in Q1 2026, an estimated $314K.
- Two Sigma Advisers first reported a position in Pediatrix Medical in Q2 2013 and held it in 29 quarters.
- Two Sigma Advisers's Pediatrix Medical position peaked at $9.37M in Q1 2021.
- 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.